Close
Almac
Achema middle east

Press Releases

Sharp invests $20 million in autoinjector & pen assembly lines to meet rising demand for injectables

Sharp Services, a leader in pharmaceutical packaging, clinical trial services & sterile manufacturing, has announced a $20 million investment in its autoinjector and pen assembly, labeling and packaging lines across various therapeutic areas at its facility in Macungie, PA. The...

CPHI Frankfurt Pharma Awards 2025 Finalists Announced

Hundreds of entries received across 14 categories showcasing innovation, sustainability, and leadership in pharma Informa Markets, has today announced the shortlist for the CPHI Pharma Awards 2025, recognising outstanding achievements across pharmaceutical innovation, manufacturing, sustainability, leadership and women in pharma. The...

Sapio Sciences and Ultima Genomics Partner to Advance Multi-Omics Research

Partnership delivers global, end-to-end solutions to accelerate genomics research Sapio Sciences, the science-awareTM lab informatics platform, today announced a strategic partnership with Ultima Genomics. The collaboration will make multi-omics workflows more accessible and streamlined for researchers by integrating Sapio’s AI-powered lab informatics...

Symeres acquiries DGr Pharma to enhance regulatory expertise and broaden its biopharma capabilities

Symeres, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announces the acquisition of DGr Pharma, a drug development-focused consultancy, to expand its integrated early-stage drug development services and accelerate IND-enabling capabilities for biopharma clients. The acquisition is...

CPHI Frankfurt 2025 to welcome more than 60,000 pharma professionals as the global event returns to Germany

Informa Markets will once again welcome the global pharmaceutical industry to CPHI Frankfurt 2025, running from October 28 to 30 at Messe Frankfurt. The three-day event is expected to draw more than 63,000 attendees, with six content theatres, more than...

Syntegon delivers strong growth and EBITDA improvements in first half of 2025

Successful growth strategy delivers sales growth in H1 of +11% versus prior year to €824m Strong growth momentum in the Pharma segment EBITDA up +41% to €127m, with margin expanding 300 bps to 15.5%.; all business units contributing ...

Reliable Labeling at Cryogenic Temperatures

In the pharmaceutical cold chain, labels must perform from +8 °C down to –196 °C in liquid nitrogen. At such extremes, conventional adhesives lose tack and ice films hinder adhesion. Melsungen, August 26, 2025 Biopharmaceuticals such as vaccines and advanced therapy...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »